nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—Infestation—Docetaxel—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Mitotane—Dyspepsia—Sunitinib—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Mitotane—Hypertension—Irinotecan—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Mitotane—Decreased appetite—Sunitinib—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Mitotane—Mental disability—Doxorubicin—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Mitotane—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Mitotane—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Mitotane—Pain—Sunitinib—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Mitotane—Hypertension—Gemcitabine—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Mitotane—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Mitotane—Asthenia—Tamoxifen—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Mitotane—Confusional state—Irinotecan—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Mitotane—Asthenia—Erlotinib—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Mitotane—Infection—Irinotecan—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Mitotane—Shock—Irinotecan—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Mitotane—Nervous system disorder—Irinotecan—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Mitotane—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Mitotane—Hepatitis—Docetaxel—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Mitotane—Diarrhoea—Tamoxifen—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Mitotane—Lethargy—Epirubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Mitotane—Infection—Gemcitabine—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Mitotane—Confusional state—Fluorouracil—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Mitotane—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Mitotane—Body temperature increased—Sunitinib—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Mitotane—Diarrhoea—Erlotinib—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Mitotane—Connective tissue disorder—Docetaxel—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Mitotane—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Mitotane—Urethral disorder—Docetaxel—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Mitotane—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Mitotane—Anorexia—Irinotecan—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Mitotane—Infection—Fluorouracil—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Mitotane—Diplopia—Epirubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Mitotane—Osteoarthritis—Epirubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Mitotane—Skin disorder—Gemcitabine—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Mitotane—Nervous system disorder—Fluorouracil—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Mitotane—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Mitotane—Visual impairment—Docetaxel—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Mitotane—Dizziness—Tamoxifen—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Mitotane—Hypotension—Irinotecan—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Mitotane—Anorexia—Gemcitabine—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Mitotane—Dizziness—Erlotinib—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Mitotane—Anorexia—Fluorouracil—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Mitotane—Hypotension—Gemcitabine—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Mitotane—Eye disorder—Docetaxel—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Mitotane—Flushing—Docetaxel—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Mitotane—Vomiting—Tamoxifen—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Mitotane—Paraesthesia—Irinotecan—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Mitotane—Lethargy—Doxorubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Mitotane—Hypotension—Fluorouracil—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Mitotane—Hypersensitivity—Sunitinib—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Mitotane—Rash—Tamoxifen—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Mitotane—Dermatitis—Tamoxifen—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Mitotane—Ataxia—Epirubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Mitotane—Vomiting—Erlotinib—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Mitotane—Somnolence—Irinotecan—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Mitotane—Headache—Tamoxifen—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Mitotane—Rash—Erlotinib—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Mitotane—Dermatitis—Erlotinib—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Mitotane—Angiopathy—Docetaxel—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Mitotane—Dyspepsia—Irinotecan—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Mitotane—Headache—Erlotinib—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Mitotane—Diplopia—Doxorubicin—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Mitotane—Osteoarthritis—Doxorubicin—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Mitotane—Paraesthesia—Gemcitabine—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Mitotane—Asthenia—Sunitinib—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Mitotane—Decreased appetite—Irinotecan—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Mitotane—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Mitotane—Somnolence—Gemcitabine—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Mitotane—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Mitotane—Paraesthesia—Fluorouracil—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Mitotane—Breast disorder—Epirubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Mitotane—Pain—Irinotecan—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Mitotane—Mental disorder—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Mitotane—Somnolence—Fluorouracil—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Mitotane—Malnutrition—Docetaxel—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Mitotane—Decreased appetite—Gemcitabine—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Mitotane—Dyspepsia—Fluorouracil—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Mitotane—Nausea—Tamoxifen—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Mitotane—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Mitotane—Muscular weakness—Epirubicin—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Mitotane—Pain—Gemcitabine—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Mitotane—Nausea—Erlotinib—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Mitotane—Decreased appetite—Fluorouracil—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Mitotane—Diarrhoea—Sunitinib—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Mitotane—Dysgeusia—Docetaxel—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Mitotane—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Mitotane—Ataxia—Doxorubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Mitotane—Feeling abnormal—Irinotecan—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Mitotane—Pain—Fluorouracil—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Mitotane—Dizziness—Sunitinib—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Mitotane—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Mitotane—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Mitotane—Breast disorder—Doxorubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Mitotane—Body temperature increased—Irinotecan—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Mitotane—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Mitotane—Anaemia—Docetaxel—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Mitotane—Muscular weakness—Doxorubicin—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Mitotane—Vomiting—Sunitinib—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Mitotane—Body temperature increased—Gemcitabine—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Mitotane—Neutropenia—Epirubicin—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Mitotane—Rash—Sunitinib—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Mitotane—Dermatitis—Sunitinib—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Mitotane—Headache—Sunitinib—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Mitotane—Body temperature increased—Fluorouracil—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Mitotane—Hypersensitivity—Irinotecan—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Mitotane—Hypertension—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Mitotane—Infestation—Epirubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Mitotane—Drowsiness—Epirubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Mitotane—Infestation NOS—Epirubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Mitotane—Nausea—Sunitinib—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Mitotane—Asthenia—Irinotecan—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Mitotane—Neutropenia—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Mitotane—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Mitotane—Asthenia—Gemcitabine—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Mitotane—Haematuria—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Mitotane—Confusional state—Docetaxel—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Mitotane—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Mitotane—Infection—Docetaxel—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Mitotane—Diarrhoea—Irinotecan—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Mitotane—Shock—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Mitotane—Nervous system disorder—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Mitotane—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Mitotane—Infestation NOS—Doxorubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Mitotane—Infestation—Doxorubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Mitotane—Drowsiness—Doxorubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Mitotane—Skin disorder—Docetaxel—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Mitotane—Diarrhoea—Gemcitabine—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Mitotane—Dizziness—Irinotecan—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Mitotane—Anorexia—Docetaxel—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Mitotane—Hepatitis—Epirubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Mitotane—Diarrhoea—Fluorouracil—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Mitotane—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Mitotane—Hypotension—Docetaxel—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Mitotane—Haematuria—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Mitotane—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Mitotane—Urethral disorder—Epirubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Mitotane—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Mitotane—Vomiting—Irinotecan—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Mitotane—Dizziness—Fluorouracil—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Mitotane—Visual impairment—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Mitotane—Rash—Irinotecan—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Mitotane—Dermatitis—Irinotecan—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Mitotane—Headache—Irinotecan—pancreatic cancer	0.001	0.001	CcSEcCtD
Mitotane—Paraesthesia—Docetaxel—pancreatic cancer	0.000993	0.000993	CcSEcCtD
Mitotane—Vomiting—Gemcitabine—pancreatic cancer	0.00099	0.00099	CcSEcCtD
Mitotane—Somnolence—Docetaxel—pancreatic cancer	0.000983	0.000983	CcSEcCtD
Mitotane—Rash—Gemcitabine—pancreatic cancer	0.000982	0.000982	CcSEcCtD
Mitotane—Dermatitis—Gemcitabine—pancreatic cancer	0.000981	0.000981	CcSEcCtD
Mitotane—Eye disorder—Epirubicin—pancreatic cancer	0.000981	0.000981	CcSEcCtD
Mitotane—Headache—Gemcitabine—pancreatic cancer	0.000976	0.000976	CcSEcCtD
Mitotane—Flushing—Epirubicin—pancreatic cancer	0.000974	0.000974	CcSEcCtD
Mitotane—Vomiting—Fluorouracil—pancreatic cancer	0.000974	0.000974	CcSEcCtD
Mitotane—Dyspepsia—Docetaxel—pancreatic cancer	0.000973	0.000973	CcSEcCtD
Mitotane—Hepatitis—Doxorubicin—pancreatic cancer	0.000971	0.000971	CcSEcCtD
Mitotane—Rash—Fluorouracil—pancreatic cancer	0.000966	0.000966	CcSEcCtD
Mitotane—Dermatitis—Fluorouracil—pancreatic cancer	0.000965	0.000965	CcSEcCtD
Mitotane—Decreased appetite—Docetaxel—pancreatic cancer	0.000961	0.000961	CcSEcCtD
Mitotane—Headache—Fluorouracil—pancreatic cancer	0.000959	0.000959	CcSEcCtD
Mitotane—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000959	0.000959	CcSEcCtD
Mitotane—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000954	0.000954	CcSEcCtD
Mitotane—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000954	0.000954	CcSEcCtD
Mitotane—Angiopathy—Epirubicin—pancreatic cancer	0.000952	0.000952	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—pancreatic cancer	0.000952	0.000952	CcSEcCtD
Mitotane—Nausea—Irinotecan—pancreatic cancer	0.00095	0.00095	CcSEcCtD
Mitotane—Pain—Docetaxel—pancreatic cancer	0.000945	0.000945	CcSEcCtD
Mitotane—Visual impairment—Doxorubicin—pancreatic cancer	0.000936	0.000936	CcSEcCtD
Mitotane—Nausea—Gemcitabine—pancreatic cancer	0.000925	0.000925	CcSEcCtD
Mitotane—Mental disorder—Epirubicin—pancreatic cancer	0.000919	0.000919	CcSEcCtD
Mitotane—Malnutrition—Epirubicin—pancreatic cancer	0.000914	0.000914	CcSEcCtD
Mitotane—Feeling abnormal—Docetaxel—pancreatic cancer	0.000911	0.000911	CcSEcCtD
Mitotane—Nausea—Fluorouracil—pancreatic cancer	0.00091	0.00091	CcSEcCtD
Mitotane—Eye disorder—Doxorubicin—pancreatic cancer	0.000907	0.000907	CcSEcCtD
Mitotane—Flushing—Doxorubicin—pancreatic cancer	0.000901	0.000901	CcSEcCtD
Mitotane—Dysgeusia—Epirubicin—pancreatic cancer	0.000895	0.000895	CcSEcCtD
Mitotane—Angiopathy—Doxorubicin—pancreatic cancer	0.000881	0.000881	CcSEcCtD
Mitotane—Body temperature increased—Docetaxel—pancreatic cancer	0.000874	0.000874	CcSEcCtD
Mitotane—Vision blurred—Epirubicin—pancreatic cancer	0.000861	0.000861	CcSEcCtD
Mitotane—Mental disorder—Doxorubicin—pancreatic cancer	0.000851	0.000851	CcSEcCtD
Mitotane—Malnutrition—Doxorubicin—pancreatic cancer	0.000845	0.000845	CcSEcCtD
Mitotane—Anaemia—Epirubicin—pancreatic cancer	0.000844	0.000844	CcSEcCtD
Mitotane—Dysgeusia—Doxorubicin—pancreatic cancer	0.000828	0.000828	CcSEcCtD
Mitotane—Vertigo—Epirubicin—pancreatic cancer	0.000821	0.000821	CcSEcCtD
Mitotane—Hypersensitivity—Docetaxel—pancreatic cancer	0.000814	0.000814	CcSEcCtD
Mitotane—Vision blurred—Doxorubicin—pancreatic cancer	0.000797	0.000797	CcSEcCtD
Mitotane—Asthenia—Docetaxel—pancreatic cancer	0.000793	0.000793	CcSEcCtD
Mitotane—Hypertension—Epirubicin—pancreatic cancer	0.000789	0.000789	CcSEcCtD
Mitotane—Anaemia—Doxorubicin—pancreatic cancer	0.000781	0.000781	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000772	0.000772	CcSEcCtD
Mitotane—Vertigo—Doxorubicin—pancreatic cancer	0.000759	0.000759	CcSEcCtD
Mitotane—Diarrhoea—Docetaxel—pancreatic cancer	0.000756	0.000756	CcSEcCtD
Mitotane—Confusional state—Epirubicin—pancreatic cancer	0.000752	0.000752	CcSEcCtD
Mitotane—Infection—Epirubicin—pancreatic cancer	0.000741	0.000741	CcSEcCtD
Mitotane—Shock—Epirubicin—pancreatic cancer	0.000734	0.000734	CcSEcCtD
Mitotane—Nervous system disorder—Epirubicin—pancreatic cancer	0.000731	0.000731	CcSEcCtD
Mitotane—Dizziness—Docetaxel—pancreatic cancer	0.000731	0.000731	CcSEcCtD
Mitotane—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00073	0.00073	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—pancreatic cancer	0.00073	0.00073	CcSEcCtD
Mitotane—Skin disorder—Epirubicin—pancreatic cancer	0.000724	0.000724	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000715	0.000715	CcSEcCtD
Mitotane—Anorexia—Epirubicin—pancreatic cancer	0.000711	0.000711	CcSEcCtD
Mitotane—Vomiting—Docetaxel—pancreatic cancer	0.000703	0.000703	CcSEcCtD
Mitotane—Rash—Docetaxel—pancreatic cancer	0.000697	0.000697	CcSEcCtD
Mitotane—Hypotension—Epirubicin—pancreatic cancer	0.000697	0.000697	CcSEcCtD
Mitotane—Dermatitis—Docetaxel—pancreatic cancer	0.000696	0.000696	CcSEcCtD
Mitotane—Confusional state—Doxorubicin—pancreatic cancer	0.000696	0.000696	CcSEcCtD
Mitotane—Headache—Docetaxel—pancreatic cancer	0.000692	0.000692	CcSEcCtD
Mitotane—Infection—Doxorubicin—pancreatic cancer	0.000685	0.000685	CcSEcCtD
Mitotane—Shock—Doxorubicin—pancreatic cancer	0.000679	0.000679	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000677	0.000677	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000675	0.000675	CcSEcCtD
Mitotane—Skin disorder—Doxorubicin—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Mitotane—Paraesthesia—Epirubicin—pancreatic cancer	0.000669	0.000669	CcSEcCtD
Mitotane—Somnolence—Epirubicin—pancreatic cancer	0.000663	0.000663	CcSEcCtD
Mitotane—Anorexia—Doxorubicin—pancreatic cancer	0.000658	0.000658	CcSEcCtD
Mitotane—Nausea—Docetaxel—pancreatic cancer	0.000657	0.000657	CcSEcCtD
Mitotane—Dyspepsia—Epirubicin—pancreatic cancer	0.000656	0.000656	CcSEcCtD
Mitotane—Decreased appetite—Epirubicin—pancreatic cancer	0.000648	0.000648	CcSEcCtD
Mitotane—Hypotension—Doxorubicin—pancreatic cancer	0.000645	0.000645	CcSEcCtD
Mitotane—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000644	0.000644	CcSEcCtD
Mitotane—Pain—Epirubicin—pancreatic cancer	0.000638	0.000638	CcSEcCtD
Mitotane—Paraesthesia—Doxorubicin—pancreatic cancer	0.000619	0.000619	CcSEcCtD
Mitotane—Feeling abnormal—Epirubicin—pancreatic cancer	0.000614	0.000614	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—pancreatic cancer	0.000613	0.000613	CcSEcCtD
Mitotane—Dyspepsia—Doxorubicin—pancreatic cancer	0.000607	0.000607	CcSEcCtD
Mitotane—Decreased appetite—Doxorubicin—pancreatic cancer	0.0006	0.0006	CcSEcCtD
Mitotane—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000596	0.000596	CcSEcCtD
Mitotane—Pain—Doxorubicin—pancreatic cancer	0.00059	0.00059	CcSEcCtD
Mitotane—Body temperature increased—Epirubicin—pancreatic cancer	0.000589	0.000589	CcSEcCtD
Mitotane—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000568	0.000568	CcSEcCtD
Mitotane—Hypersensitivity—Epirubicin—pancreatic cancer	0.000549	0.000549	CcSEcCtD
Mitotane—Body temperature increased—Doxorubicin—pancreatic cancer	0.000545	0.000545	CcSEcCtD
Mitotane—Asthenia—Epirubicin—pancreatic cancer	0.000535	0.000535	CcSEcCtD
Mitotane—Diarrhoea—Epirubicin—pancreatic cancer	0.00051	0.00051	CcSEcCtD
Mitotane—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000508	0.000508	CcSEcCtD
Mitotane—Asthenia—Doxorubicin—pancreatic cancer	0.000495	0.000495	CcSEcCtD
Mitotane—Dizziness—Epirubicin—pancreatic cancer	0.000493	0.000493	CcSEcCtD
Mitotane—Vomiting—Epirubicin—pancreatic cancer	0.000474	0.000474	CcSEcCtD
Mitotane—Diarrhoea—Doxorubicin—pancreatic cancer	0.000472	0.000472	CcSEcCtD
Mitotane—Rash—Epirubicin—pancreatic cancer	0.00047	0.00047	CcSEcCtD
Mitotane—Dermatitis—Epirubicin—pancreatic cancer	0.00047	0.00047	CcSEcCtD
Mitotane—Headache—Epirubicin—pancreatic cancer	0.000467	0.000467	CcSEcCtD
Mitotane—Dizziness—Doxorubicin—pancreatic cancer	0.000456	0.000456	CcSEcCtD
Mitotane—Nausea—Epirubicin—pancreatic cancer	0.000443	0.000443	CcSEcCtD
Mitotane—Vomiting—Doxorubicin—pancreatic cancer	0.000439	0.000439	CcSEcCtD
Mitotane—Rash—Doxorubicin—pancreatic cancer	0.000435	0.000435	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—pancreatic cancer	0.000435	0.000435	CcSEcCtD
Mitotane—Headache—Doxorubicin—pancreatic cancer	0.000432	0.000432	CcSEcCtD
Mitotane—Nausea—Doxorubicin—pancreatic cancer	0.00041	0.00041	CcSEcCtD
